EP Patent

EP0792643A1 — Use of an aldose reductase inhibitor for reducing non-cardiac tissue damage

Assigned to Pfizer Inc · Expires 1997-09-03 · 29y expired

What this patent protects

The use of an aldose reductase inhibitor for the manufacture of a medicament for reducing non-cardiac tissue damage resulting from ischemia in a mammal.

USPTO Abstract

The use of an aldose reductase inhibitor for the manufacture of a medicament for reducing non-cardiac tissue damage resulting from ischemia in a mammal.

Drugs covered by this patent

Patent Metadata

Patent number
EP0792643A1
Jurisdiction
EP
Classification
—
Expires
1997-09-03
Drug substance claim
No
Drug product claim
No
Assignee
Pfizer Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.